Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines

7 Nov 2024

Abstract excerpt

This review addresses the ongoing global challenge posed by emerging and evolving viral diseases, underscoring the need for innovative vaccine development strategies. It focuses on the modern approaches to creating vaccines based on recombinant proteins produced in different expression systems, including bacteria, yeast, plants, insects, and mammals. This review analyses the advantages, limitations, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39596049
DOI: 10.3390/ijms252211979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for VaccinesPMID 39596049Read ↗

Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic moleculesSemantic proximity Read ↗

Advances and challenges in enveloped virus-like particle (VLP)-based vaccinesSemantic proximity Read ↗

Application of Baculovirus Expression Vector System (BEVS) in Vaccine DevelopmentSemantic proximity Read ↗

The use of viral vectors in vaccine developmentSemantic proximity Read ↗

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read ↗

Plant-Derived Recombinant Vaccines against Zoonotic VirusesSemantic proximity Read ↗

Virus‐like particles as powerful vaccination strategy against human virusesSemantic proximity Read ↗

Recombinant viruses as vaccines against viral diseasesSemantic proximity Read ↗

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read ↗

Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expressionSemantic proximity Read ↗

Production of SARS-CoV-2 Virus-Like Particles in Insect CellsSemantic proximity Read ↗

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.